Helios Astileu (BSE:HEAL) Research & Development: lei Mil (TTM As of . 20)


BSE:HEAL Helios SA Astileu BSE:HEAL
9 GF Score
Price lei24.00
View Full Analysis

What is Helios Astileu Research & Development?

Helios Astileu BSE:HEAL 9 Research & Development is lei Mil as of . 20. GuruFocus rates BSE:HEAL with a GF Score™ of 9/100.

Research & Development is the aggregate amount of research and development expenses during the year. Helios Astileu's Research & Development for the six months ended in . 20 was lei0.00 Mil. Helios Astileu does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Helios Astileu  (BSE:HEAL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Helios Astileu Research & Development Related Terms

Helios Astileu Research & Development Historical Data

* Premium members only.

The historical data trend for Helios Astileu's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helios Astileu Research & Development Chart

Helios Astileu Annual Data
Trend
Research & Development

Helios Astileu Semi-Annual Data
Research & Development
BSE:HEAL
9GF Score
Helios SA Astileu BSE:HEAL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helios Astileu Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of lei Mil mean?
Helios Astileu (BSE:HEAL) has a Research & Development of lei Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Helios Astileu and its competitors.
Is Helios Astileu's Research & Development too high?
Helios Astileu's current Research & Development is lei Mil. Overall, Helios Astileu has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Helios Astileu's Research & Development compare to competitors?
Helios Astileu's Research & Development of lei Mil can be compared against companies in the Building Materials industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Building Materials company?
A good Research & Development depends on the Building Materials industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Helios Astileu and its competitors. Helios Astileu's current Research & Development is lei Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helios Astileu stock overvalued right now?
Helios Astileu (BSE:HEAL) has a current Research & Development of lei Mil. The current Research & Development is lei Mil. Helios Astileu's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Helios Astileu (BSE:HEAL), the current Research & Development is lei Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helios Astileu Business Description

Address Astileu, no. 236, Street Principala, Bihor County, Astileu, ROU, 417020
Helios SA Astileu is a manufacturer of refractory ceramic products. The company offers refractory bricks, short and long wedge bricks; refractory mortars; acid-proof refractory stoneware, ply products, bricks, and tubes; refractory and micronized clays; refractory concretes, and ceramic putties. It also provides building materials, such as red bricks, ceramic blocks with vertical hollows, decorative bricks for fence, lime paste products, and ceramic tiles, as well as ornamental ceramic tiles, decorative ceramic stones, ceramic grills, and chimney systems.
9GF Score

Get the complete analysis for BSE:HEAL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei24.00
Price